Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Intermittent hypoxia induces murine macrophage foam cell formation by IKK-β-dependent NF-κB pathway activation.

Imamura T, Poulsen O, Haddad GG.

J Appl Physiol (1985). 2016 Sep 1;121(3):670-7. doi: 10.1152/japplphysiol.00307.2016. Epub 2016 Jul 28.

PMID:
27471237
2.

Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis.

Qin L, Zhu N, Ao BX, Liu C, Shi YN, Du K, Chen JX, Zheng XL, Liao DF.

Int J Mol Sci. 2016 Mar 22;17(3):429. doi: 10.3390/ijms17030429. Review.

3.

Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages.

Tang C, Houston BA, Storey C, LeBoeuf RC.

J Lipid Res. 2016 May;57(5):848-57. doi: 10.1194/jlr.M065797. Epub 2016 Mar 17.

PMID:
26989082
4.

Serum amyloid A impairs the antiinflammatory properties of HDL.

Han CY, Tang C, Guevara ME, Wei H, Wietecha T, Shao B, Subramanian S, Omer M, Wang S, O'Brien KD, Marcovina SM, Wight TN, Vaisar T, de Beer MC, de Beer FC, Osborne WR, Elkon KB, Chait A.

J Clin Invest. 2016 Jan;126(1):266-81. doi: 10.1172/JCI83475. Epub 2015 Dec 7. Erratum in: J Clin Invest. 2016 Feb;126(2):796.

5.

Concentration-Dependent Diversifcation Effects of Free Cholesterol Loading on Macrophage Viability and Polarization.

Xu X, Zhang A, Li N, Li PL, Zhang F.

Cell Physiol Biochem. 2015;37(2):419-31. doi: 10.1159/000430365. Epub 2015 Aug 28.

6.

Increased Circulating Cathepsin K in Patients with Chronic Heart Failure.

Zhao G, Li Y, Cui L, Li X, Jin Z, Han X, Fang E, Gao Y, Zhou D, Jiang H, Jin X, Piao G, Li X, Yang G, Jin J, Zhu E, Piao M, Piao L, Yuan K, Lei Y, Ding D, Jin C, Nan Y, Cheng X.

PLoS One. 2015 Aug 24;10(8):e0136093. doi: 10.1371/journal.pone.0136093. eCollection 2015.

7.

Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.

Chami B, Barrie N, Cai X, Wang X, Paul M, Morton-Chandra R, Sharland A, Dennis JM, Freedman SB, Witting PK.

Int J Mol Sci. 2015 May 15;16(5):11101-24. doi: 10.3390/ijms160511101.

8.

Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway.

Wu Z, Yu Y, Liu C, Xiong Y, Montani JP, Yang Z, Ming XF.

Aging (Albany NY). 2015 Jan;7(1):70-81.

9.

Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation.

Progatzky F, Sangha NJ, Yoshida N, McBrien M, Cheung J, Shia A, Scott J, Marchesi JR, Lamb JR, Bugeon L, Dallman MJ.

Nat Commun. 2014 Dec 23;5:5864. doi: 10.1038/ncomms6864.

10.

MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.

Meiler S, Baumer Y, Toulmin E, Seng K, Boisvert WA.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):323-31. doi: 10.1161/ATVBAHA.114.304878. Epub 2014 Dec 18.

11.

p38 MAPK in cardioprotection - are we there yet?

Martin ED, Bassi R, Marber MS.

Br J Pharmacol. 2015 Apr;172(8):2101-13. doi: 10.1111/bph.12901. Epub 2014 Nov 24. Review.

12.

miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.

Distel E, Barrett TJ, Chung K, Girgis NM, Parathath S, Essau CC, Murphy AJ, Moore KJ, Fisher EA.

Circ Res. 2014 Oct 10;115(9):759-69. doi: 10.1161/CIRCRESAHA.115.304164. Epub 2014 Sep 8.

13.

Ultraviolet A-induced cathepsin K expression is mediated via MAPK/AP-1 pathway in human dermal fibroblasts.

Xu Q, Hou W, Zheng Y, Liu C, Gong Z, Lu C, Lai W, Maibach HI.

PLoS One. 2014 Jul 21;9(7):e102732. doi: 10.1371/journal.pone.0102732. eCollection 2014.

14.

p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity.

Yu Y, Rajapakse AG, Montani JP, Yang Z, Ming XF.

Cardiovasc Diabetol. 2014 Jul 18;13:113. doi: 10.1186/s12933-014-0113-z.

15.

High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation.

McGrath KC, Li XH, Whitworth PT, Kasz R, Tan JT, McLennan SV, Celermajer DS, Barter PJ, Rye KA, Heather AK.

J Lipid Res. 2014 Mar;55(3):421-30. doi: 10.1194/jlr.M043281. Epub 2013 Dec 17.

16.

Reconstituted high-density lipoprotein modulates activation of human leukocytes.

Spirig R, Schaub A, Kropf A, Miescher S, Spycher MO, Rieben R.

PLoS One. 2013 Aug 14;8(8):e71235. doi: 10.1371/journal.pone.0071235. eCollection 2013.

17.

TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

Ishibashi M, Sayers S, D'Armiento JM, Tall AR, Welch CL.

Atherosclerosis. 2013 Jul;229(1):52-61. doi: 10.1016/j.atherosclerosis.2013.03.035. Epub 2013 Apr 9.

18.

Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.

Lee CH, Lee YJ, Kim JH, Lim JH, Kim JH, Han W, Lee SH, Noh GJ, Lee SW.

J Virol. 2013 Jun;87(12):7064-74. doi: 10.1128/JVI.00405-13. Epub 2013 Apr 17.

19.

The UPR in atherosclerosis.

Zhou AX, Tabas I.

Semin Immunopathol. 2013 May;35(3):321-32. doi: 10.1007/s00281-013-0372-x. Epub 2013 Apr 4. Review.

20.

Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.

Umemoto T, Han CY, Mitra P, Averill MM, Tang C, Goodspeed L, Omer M, Subramanian S, Wang S, Den Hartigh LJ, Wei H, Kim EJ, Kim J, O'Brien KD, Chait A.

Circ Res. 2013 May 10;112(10):1345-54. doi: 10.1161/CIRCRESAHA.111.300581. Epub 2013 Mar 15.

Supplemental Content

Support Center